SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-19-005318
Filing Date
2019-02-06
Accepted
2019-02-06 16:06:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tv512408_sc13g.htm SC 13G 41037
  Complete submission text file 0001144204-19-005318.txt   42431
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46247 | Film No.: 19571617
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address BUILDING 1037,XIHU GOLF, ZHIGANG ROAD 200, HANGZHOU ZHEJANG F4 310008
Business Address
Li Dapeng (Filed by) CIK: 0001765591 (see all company filings)

Type: SC 13G